Australia's largest stock trading and investment forum Australia's #1 stock forum

CXO

Click for more information

10.9%

12.8¢ core lithium ltd

Banter and general comments, page-29176

First 29176 Last

Share
Profile

Follow
Comptonfarm

1,127 Posts.

171

20/07/23

20:26

Post #: 68897023
Share

Originally posted by barneydigs: ↑

I think the main issue in terms of why we are not priced higher and have so much short interest is the lack of transparency on the price we will achieve via our offtake agreements. I know as retail we have heard SB say 'look to replicate offtake' and some conflicting messages around floor and ceilings, but at the moment we really don't know.

Of course they are commercial in confidence so management can't release the details. So we will need to wait until a quarterly report for a quarter where we shipped spod under the offtake agreements and compare the income per tonne to the spot price at the time to get a good idea of what it all looks like. Unless they are close enough to steady state to provide some FY24 production and revenue guidance in the quarterly?

I am confident we have a good price arrangement but institutions would be cautious on investing to much (and some any at all) without certainty on the offtake prices. And the shorts would be playing on the uncertainty. We know pretty much everything except the price we will get - the rerate will happen when (if) the price is confirmed to be favourable.

Expand

I would suggest that whilst us retail don't know about off take prices, the shorts do definately know the off take price details.

CXO Price at posting: 91.5¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

There are more pages in this discussion • 10,137 more messages in this thread...

First 29176 Last

Add CXO (ASX) to my watchlist

(20min delay)
Last 12.8¢		Change 0.013(10.9%)		Mkt cap ! $267.8M

Open	High	Low	Value	Volume
12.0¢	13.0¢	11.5¢	$1.732M	14.12M

Buyers (Bids)

No.	Vol.	Price($)
29	2567440	12.5¢

Sellers (Offers)

Price($)	Vol.	No.
13.0¢	9040919	74

View Market Depth

No.	Vol.	Price($)
27	2632150	0.125
28	2035610	0.120
52	7339847	0.115
100	6160008	0.110
67	4897584	0.105

Price($)	Vol.	No.
0.130	9140919	78
0.135	2682416	45
0.140	1331220	29
0.145	1340987	26
0.150	1118052	30

Last trade - 14.31pm 07/10/2024 (20 minute delay)

CXO (ASX) Chart